Fifteen years commercial experience in cellular therapy related to both Oncology and Regenerative Medicine. Development of immunomagentic cell selection technologies using both immunomagnetic particles and ferrofluids. Lead for the production of monoclonal antibodies and other biologics to pharmaceutical standards. Experience in preparing documentation for both US and European regulatory bodies to support products through Phase I-III and commercial launch. Familiar with both pharmaceutical and medical device requirements in major geographies. Previous team leader supporting technical sales force in the areas of Oncology, Haematology and Transplantation Medicine.